Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
National Defense Authorization Act for Fiscal Year 2024; Defense Appropriations Act for Fiscal Year 2024; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260).
National Defense Authorization Act for Fiscal Year 2023; Defense Appropriations Act for Fiscal Year 2023; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2026 · first_quarter · 1A
FY27 NDAA, FY27 Appropriations
FY27 NDAA, FY27 Appropriations
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| EMERGENT BIOSOLUTIONS INC. |
| 47 |
| 2014–2024 |
| AGUSTAWESTLAND NORTH AMERICA, INC. | 43 | 2007–2016 |
| LOCKHEED MARTIN CORPORATION | 41 | 1999–2014 |
| KUCHERA INDUSTRIES | 40 | 2001–2009 |
| AEROJET ROCKETDYNE INC | 37 | 2015–2023 |
| CTIA | 30 | 2019–2026 |
| VITAL PROBES INC | 30 | 2001–2012 |
| RAYDIANCE | 29 | 2004–2011 |
| ARGONST | 28 | 2002–2011 |
| Absolute Software Corporation | 28 | 2019–2026 |
| GENERAL MOTORS COMPANY | 27 | 2020–2026 |
| GOOD TECHNOLOGY | 26 | 2009–2015 |
| BYHEART, INC. | 24 | 2020–2025 |
| UNIVERSITY OF PITTSBURG MEDICAL CENTER (A K A UPMC) | 24 | 2004–2011 |
| Iomax USA, Inc. | 23 | 2017–2022 |
| SENSOR ELECTRONIC TECHNOLOGY, INC. | 22 | 2007–2013 |
| BAE SYSTEMS (FORMERLY KNOWN AS UNITED DEFENSE) | 21 | 1999–2009 |
| VIRUS DETECTION SYSTEMS COMPANY LLC | 21 | 2004–2010 |
| AURORA FLIGHT SCIENCES | 18 | 2016–2019 |
| PHARMATHENE, INC. | 18 | 2003–2009 |
| SARNOFF CORPORATION | 16 | 2000–2008 |
| DTEX SYSTEMS | 15 | 2016–2019 |
| PMT GROUP | 15 | 2022–2026 |
| SCOT INC | 15 | 2003–2008 |
| FLEX (FKA FLEXTRONICS INTERNATIONAL USA, INC) | 14 | 2013–2016 |
| FUGRO PELAGOS INC | 14 | 2004–2009 |
| LYNDRA THERAPEUTICS | 14 | 2019–2022 |
| ELECTRA.AERO INC. | 13 | 2021–2024 |
| SHUMAR INDUSTRIES | 13 | 2008–2010 |
| AMERIALERT, LLC | 12 | 2009–2011 |
| DEFENSE GROUP INC | 11 | 2006–2008 |
| EX ONE COMPANY LLC | 11 | 2008–2010 |
| NATIONAL REHABILITATION HOSPITAL | 11 | 2012–2014 |
| RVJ CAPITAL | 11 | 2016–2019 |
| ALENIAAERMACCHI NORTH AMERICA | 10 | 2013–2015 |
| AQUANANO LLC | 10 | 2008–2009 |
| DSCI | 9 | 2002–2006 |
| KAISER-HILL CO | 9 | 1999–2005 |
| LASEN INC | 9 | 2005–2007 |
| PARION SCIENCES INCORPORATED | 8 | 2009–2010 |
| ECONOMIC STRATEGIES GROUP | 7 | 2003–2005 |
| GREFFEX INC. | 7 | 2020–2021 |
| JACKSONVILLE AIRPORT AUTHORITY | 7 | 2005–2007 |
| KAMAN DIVERSIFIED TECHNOLOGIES | 7 | 1999–2003 |
| KIMBLE'S AVIATION LOGISTICAL SERVICES INC. | 7 | 2018–2019 |
| LYONDELLBASELL | 7 | 2024–2025 |
| VIATRONIX INC | 7 | 2003–2005 |
| ACS DEFENSE INC | 6 | 2000–2003 |
| COMPUTER COALITION FOR RESPONSIBLE EXPORTS | 6 | 1999–2002 |
| INVERIS TRAINING SOLUTIONS | 6 | 2020–2021 |
| PALANTIR TECHNOLOGIES, INC. | 6 | 2021 |
| POLYKINETICS INC | 6 | 2004–2007 |
| THALES NORTH AMERICA INC | 6 | 2003–2006 |
| 5E ADVANCED MATERIALS, INC. | 5 | 2021–2024 |
| API TECHNOLOGIES CORP | 5 | 2010 |
| BOLLINGER SHIPYARDS, LLC | 5 | 2021 |
| CLEARDAY PRODUCTS LTD. | 5 | 2021 |
| FIRST FINANCIAL LOAN COMPANY | 5 | 2021 |
| GRUMMAN OLSON INDUSTRIES | 5 | 1999–2000 |
| I2STAR | 5 | 2001–2002 |
| INGALLS SHIPBUILDING | 5 | 1999–2001 |
| NORTHEAST REGIONAL CANCER INSTITUTE | 5 | 2004–2006 |
| PROCYON TECHNOLOGIES INC | 5 | 2001–2003 |
| REMIX | 5 | 2018–2019 |
| RX BIO, INC. | 5 | 2021 |
| STEADY PLATFORM, INC. | 5 | 2021 |
| U.S. ENERGY PRODUCTS LLC | 5 | 2021 |
| VIDEO NETWORK COMMUNICATIONS INC | 5 | 2001–2003 |
| ACUMENTRICS CORP | 4 | 2002–2004 |
| ALLIED SERVICES | 4 | 2001–2002 |
| COMCOSM INTERNATIONAL, INC. | 4 | 2021 |
| ERA HELICOPTERS LLC | 4 | 2012–2013 |
| G6 ENERGY CORP. | 4 | 2023 |
| LITTON SYSTEMS | 4 | 1999–2001 |
| MONGOLIA TOMORROW COALITION | 4 | 2019–2020 |
| SEMPRE | 4 | 2021 |
| STEVENS INSTITUTE OF TECHNOLOGY | 4 | 2006–2008 |
| AECOM TECHNOLOGIES INC | 3 | 2001–2004 |
| ALEGHENY TECHNOLOGIES | 3 | 2000 |
| AMERICAN ANTIBIOTICS INITIATIVE INC. | 3 | 2021 |
| ASSOCIATION & SOCIETY INSURANCE CORPORATION | 3 | 2006–2007 |
| CALIENT TECHNOLOGIES | 3 | 2021 |
| CDI MARINE | 3 | 2000 |
| JANSON COMMUNICATIONS, INC. | 3 | 2022–2023 |
| KIMBLE'S DISASTER RELIEF | 3 | 2015 |
| MAGNAPHONE INC | 3 | 2004–2005 |
| SCIENCE APPLICATIONS INTL CORP (SAIC) | 3 | 1999–2000 |
| SKF USA | 3 | 1999–2001 |
| TACTICAL INNOVATIONS LLC | 3 | 2024 |
| TELEDYNE BROWN ENGINEERING | 3 | 1999 |
| THE TETHYS GROUP | 3 | 2018 |
| ALLEGHENY TELEDYNE | 2 | 1999 |
| CAPITOL RESOURCES WASHINGTON REPRESENTATION | 2 | 2006 |
| IMMUNICOM, INC. | 2 | 2020 |
National Defense Authorization Act for Fiscal Year 2024; Defense Appropriations Act for Fiscal Year 2024; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260).
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24; NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506
University of Utah Research Park Act
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY24 NDAA, FY24 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
University of Utah Research Park Act
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2024; Defense Appropriations Act for Fiscal Year 2024; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260).
University of Utah Research Park Act
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY24 NDAA, FY24 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
University of Utah Research Park Act
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY24 NDAA, FY24 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
University of Utah Research Park Act
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2024; Defense Appropriations Act for Fiscal Year 2024; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260).
University of Utah Research Park Act
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY24 NDAA, FY24 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
University of Utah Research Park Act
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023; Defense Appropriations Act for Fiscal Year 2023; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260)
University of Utah Research Park Act
Client: COHERENT · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023 - Silicon carbide Defense Appropriations Act for Fiscal Year 2023 - Silicon carbide CHIPS for America Act; U.S. Innovation and Competition Act (S. 1260)
University of Utah Research Park Act
Client: COHERENT · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023 - Silicon carbide Defense Appropriations Act for Fiscal Year 2023 - Silicon carbide CHIPS for America Act; U.S. Innovation and Competition Act (S. 1260)
American Rescue Plan Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY22 NDAA, FY22 Appropriations, Semiconductor issues, Endless Frontier Act (from 116th), American Rescue Plan Act (HR 1319)
American Rescue Plan Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Issues related to Covid-19, FY22 NDAA, FY22 Appropriations, Semiconductor issues, Endless Frontier Act (from 116th), American Rescue Plan Act (HR 1319)
Further Continuing Appropriations and Extensions Act, 2023
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone; HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus); HR 1437 - Further Continuing Appropriations and Extensions Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; Issues related to the development, manufacture, and distribution of coronavirus vaccines
STOP Fentanyl Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
STOP Fentanyl Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
State Opioid Response Grant Authorization Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
State Opioid Response Grant Authorization Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
State Opioid Response Grant Authorization Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
Consolidated Appropriations Act, 2022
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023; Defense Appropriations Act for Fiscal Year 2023; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260)
Consolidated Appropriations Act, 2022
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023; Defense Appropriations Act for Fiscal Year 2023; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260)
Consolidated Appropriations Act, 2022
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023; Defense Appropriations Act for Fiscal Year 2023; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260)
Consolidated Appropriations Act, 2022
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
Consolidated Appropriations Act, 2022
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2022; Defense Appropriations Act for Fiscal Year 2022; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471.
Consolidated Appropriations Act, 2023
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone; HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus); HR 1437 - Further Continuing Appropriations and Extensions Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; Issues related to the development, manufacture, and distribution of coronavirus vaccines
DHS Medical Countermeasures Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
DHS Medical Countermeasures Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
CARA 3.0 Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
CARA 3.0 Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Preventing Overdoses and Saving Lives Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
Preventing Overdoses and Saving Lives Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
Further Extending Government Funding Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
Preventing Overdoses and Saving Lives Act 2.0
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
United States Innovation and Competition Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY23 NDAA, FY23 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
United States Innovation and Competition Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY23 NDAA, FY23 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
United States Innovation and Competition Act of 2021
Client: COHERENT · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023 - Silicon carbide Defense Appropriations Act for Fiscal Year 2023 - Silicon carbide CHIPS for America Act; U.S. Innovation and Competition Act (S. 1260);
United States Innovation and Competition Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY23 NDAA, FY23 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
United States Innovation and Competition Act of 2021
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023; Defense Appropriations Act for Fiscal Year 2023; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260)
United States Innovation and Competition Act of 2021
Client: COHERENT · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023 - Silicon carbide Defense Appropriations Act for Fiscal Year 2023 - Silicon carbide CHIPS for America Act; U.S. Innovation and Competition Act (S. 1260);
United States Innovation and Competition Act of 2021
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023; Defense Appropriations Act for Fiscal Year 2023; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260)
United States Innovation and Competition Act of 2021
Client: COHERENT · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023 - Silicon carbide Defense Appropriations Act for Fiscal Year 2023 - Silicon carbide CHIPS for America Act; U.S. Innovation and Competition Act (S. 1260);
United States Innovation and Competition Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY23 NDAA, FY23 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
United States Innovation and Competition Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY23 NDAA, FY23 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
United States Innovation and Competition Act of 2021
Client: GENERAL DYNAMICS · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
National Defense Authorization Act for Fiscal Year 2023; Defense Appropriations Act for Fiscal Year 2023; Shipbuilding Industrial Base Issues; R&D tax credits effort to get an amendment into the Omnibus Appropriations Act, HR 2471; U.S. Innovation and Competition Act (S. 1260)
United States Innovation and Competition Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
FY23 NDAA, FY23 Appropriations, Semiconductor issues, U.S. Innovation and Competition Act (S. 1260);
STOP Fentanyl Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
STOP Fentanyl Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
PREVENT Pandemics Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines.
PREVENT Pandemics Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
CARA 3.0 Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R. 2471 - Consolidated Appropriations Act, 2022 Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 Issues related to the development, manufacture, and distribution of coronavirus vaccines HR 3263 Outreach - DHS Medical Countermeasures Act
CARA 3.0 Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone House and Senate appropriations for FY 2023 H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021 H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021 HR 7681 - Preventing Overdoses and Saving Lives Act 2.0 S. 3799 - PREVENT Pandemics Act Issues related to the development, manufacture, and distribution of coronavirus vaccines. HR 3263 Outreach - DHS Medical Countermeasures Act
American Rescue Plan Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Issues related to Covid-19, FY22 NDAA, FY22 Appropriations, Semiconductor issues, Endless Frontier Act (from 116th), American Rescue Plan Act (HR 1319)
American Rescue Plan Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Issues related to Covid-19, FY22 NDAA, FY22 Appropriations, Semiconductor issues, Endless Frontier Act (from 116th), American Rescue Plan Act (HR 1319)
American Rescue Plan Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Issues related to Covid-19, FY22 NDAA, FY22 Appropriations, Semiconductor issues, Endless Frontier Act (from 116th), American Rescue Plan Act (HR 1319)
American Rescue Plan Act of 2021
Client: GENERAL MOTORS COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Issues related to Covid-19, FY22 NDAA, FY22 Appropriations, Semiconductor issues, Endless Frontier Act (from 116th), American Rescue Plan Act (HR 1319)
STOP Fentanyl Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; State Opioid Response (SOR) Grants funding; H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021; Substance Abuse and Mental Health Block Grant (SABG) funding; H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; HR 3263 Outreach - DHS Medical Countermeasures Act;
STOP Fentanyl Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding; Substance Abuse and Mental Health Block Grant funding; CARA 3.0 - Comprehensive Addiction and Recovery Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; S.4231 - Preparing for the Next Pandemic Act; H.R 2366 S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines;
State Opioid Response Grant Authorization Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone.
State Opioid Response Grant Authorization Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding; Substance Abuse and Mental Health Block Grant funding; CARA 3.0 - Comprehensive Addiction and Recovery Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; S.4231 - Preparing for the Next Pandemic Act; H.R 2366 S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines;
State Opioid Response Grant Authorization Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; State Opioid Response (SOR) Grants funding; H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021; Substance Abuse and Mental Health Block Grant (SABG) funding; H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; HR 3263 Outreach - DHS Medical Countermeasures Act;
State Opioid Response Grant Authorization Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone.
DHS Medical Countermeasures Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; State Opioid Response (SOR) Grants funding; H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021; Substance Abuse and Mental Health Block Grant (SABG) funding; H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; HR 3263 Outreach - DHS Medical Countermeasures Act;
CARA 3.0 Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; State Opioid Response (SOR) Grants funding; H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021; Substance Abuse and Mental Health Block Grant (SABG) funding; H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; HR 3263 Outreach - DHS Medical Countermeasures Act;
Preventing Overdoses and Saving Lives Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; State Opioid Response (SOR) Grants funding; H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021; Substance Abuse and Mental Health Block Grant (SABG) funding; H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; HR 3263 Outreach - DHS Medical Countermeasures Act;
Preventing Overdoses and Saving Lives Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding; Substance Abuse and Mental Health Block Grant funding; CARA 3.0 - Comprehensive Addiction and Recovery Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; S.4231 - Preparing for the Next Pandemic Act; H.R 2366 S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines;
Further Extending Government Funding Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; State Opioid Response (SOR) Grants funding; H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021; Substance Abuse and Mental Health Block Grant (SABG) funding; H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; HR 3263 Outreach - DHS Medical Countermeasures Act;
STOP Fentanyl Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; State Opioid Response (SOR) Grants funding; H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021; Substance Abuse and Mental Health Block Grant (SABG) funding; H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; HR 3263 Outreach - DHS Medical Countermeasures Act;
STOP Fentanyl Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding; Substance Abuse and Mental Health Block Grant funding; CARA 3.0 - Comprehensive Addiction and Recovery Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; S.4231 - Preparing for the Next Pandemic Act; H.R 2366 S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines;
CARA 3.0 Act of 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; State Opioid Response (SOR) Grants funding; H.R. 2379 - The State Opioid Response Grant Authorization Act of 2021; Substance Abuse and Mental Health Block Grant (SABG) funding; H.R. 4341; S. 987 - CARA 3.0 - Comprehensive Addiction and Recovery Act Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R 2366; S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; HR 3263 Outreach - DHS Medical Countermeasures Act;
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders".
Client: FIRST FINANCIAL LOAN COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Issues relating to Dodd-Frank Wall Street Reform and Consumer Protection Act implementation, The Consumer Financial Protection Bureau, community financial services providers, increasing access to affordable payment and credit options for working families. Financial Services and General Government Appropriations bills. Financial services provisions of CARES Act. National Defense Authorization Act; S.J. Res. 15 - Office of the Comptroller of the Currencys (OCC) True Lender rule under the Congressional Review Act (CRA)
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders".
Client: FIRST FINANCIAL LOAN COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Issues relating to Dodd-Frank Wall Street Reform and Consumer Protection Act implementation, The Consumer Financial Protection Bureau, community financial services providers, increasing access to affordable payment and credit options for working families. Financial Services and General Government Appropriations bills. Financial services provisions of CARES Act. National Defense Authorization Act; S.J. Res. 15 - Office of the Comptroller of the Currencys (OCC) True Lender rule under the Congressional Review Act (CRA)
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Comptroller of Currency relating to "National Banks and Federal Savings Associations as Lenders".
Client: FIRST FINANCIAL LOAN COMPANY · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Issues relating to Dodd-Frank Wall Street Reform and Consumer Protection Act implementation, The Consumer Financial Protection Bureau, community financial services providers, increasing access to affordable payment and credit options for working families. Financial Services and General Government Appropriations bills. Financial services provisions of CARES Act. National Defense Authorization Act; S.J. Res. 15 - Office of the Comptroller of the Currencys (OCC) True Lender rule under the Congressional Review Act (CRA)
Preparing for the Next Pandemic Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding; Substance Abuse and Mental Health Block Grant funding; CARA 3.0 - Comprehensive Addiction and Recovery Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; S.4231 - Preparing for the Next Pandemic Act; H.R 2366 S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines;
Consolidated Appropriations Act, 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding for FY 2021; H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone; Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign; H.R. 2466 The State Opioid Response Grant Authorization Act; H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce); HEROES Act - H.R. 8406 - The Heroes Act; S.4231 - Preparing for the Next Pandemic Act; HEALS Act; H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act; H.R. 133, Consolidated Appropriations Act 2021;
Commitment to Defeat the Virus and Keep America Healthy Act
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding for FY 2021; H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone; Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign; H.R. 2466 The State Opioid Response Grant Authorization Act; H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce); HEROES Act - H.R. 8406 - The Heroes Act; S.4231 - Preparing for the Next Pandemic Act; HEALS Act; H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act; H.R. 133, Consolidated Appropriations Act 2021;
Mongolia Third Neighbor Trade Act
Client: MONGOLIA TOMORROW COALITION · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Promotion of stronger trade ties between the US and Mongolia to revitalize the Mongolian cashmere industry HR 2219 and S. 1188 - Mongolia Third Neighbor Trade Act bills
Mongolia Third Neighbor Trade Act
Client: MONGOLIA TOMORROW COALITION · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Promotion of stronger trade ties between the US and Mongolia to revitalize the Mongolian cashmere industry HR 2219 and S. 1188 - Mongolia Third Neighbor Trade Act bills
Mongolia Third Neighbor Trade Act
Client: MONGOLIA TOMORROW COALITION · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Promotion of stronger trade ties between the US and Mongolia to revitalize the Mongolian cashmere industry HR 2219 and S. 1188 - Mongolia Third Neighbor Trade Act bills
Mongolia Third Neighbor Trade Act
Client: MONGOLIA TOMORROW COALITION · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Promotion of stronger trade ties between the US and Mongolia to revitalize the Mongolian cashmere industry HR 2219 and S. 1188 - Mongolia Third Neighbor Trade Act bills
State Opioid Response Grant Authorization Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
State Opioid Response Grant Authorization Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
State Opioid Response Grant Authorization Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding for FY 2021; H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone; Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign; H.R. 2466 The State Opioid Response Grant Authorization Act; H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce); HEROES Act - H.R. 8406 - The Heroes Act; S.4231 - Preparing for the Next Pandemic Act; HEALS Act; H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act; H.R. 133, Consolidated Appropriations Act 2021;
State Opioid Response Grant Authorization Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding for FY 2021; H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone; Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign; H.R. 2466 The State Opioid Response Grant Authorization Act; H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce); HEROES Act - H.R. 8406 - The Heroes Act; S.4231 - Preparing for the Next Pandemic Act; HEALS Act; H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act; H.R. 133, Consolidated Appropriations Act 2021;
Strengthening America's Strategic National Stockpile Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Strengthening America's Strategic National Stockpile Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding for FY 2021; H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone; Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign; H.R. 2466 The State Opioid Response Grant Authorization Act; H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce); HEROES Act - H.R. 8406 - The Heroes Act; S.4231 - Preparing for the Next Pandemic Act; HEALS Act; H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act; H.R. 133, Consolidated Appropriations Act 2021;
Strengthening America's Strategic National Stockpile Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Strengthening America's Strategic National Stockpile Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Plasma Donation Awareness Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Plasma Donation Awareness Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding for FY 2021; H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone; Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign; H.R. 2466 The State Opioid Response Grant Authorization Act; H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce); HEROES Act - H.R. 8406 - The Heroes Act; S.4231 - Preparing for the Next Pandemic Act; HEALS Act; H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act; H.R. 133, Consolidated Appropriations Act 2021;
Plasma Donation Awareness Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Plasma Donation Awareness Act of 2020
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Making emergency supplemental appropriations for the fiscal year ending September 30, 2021, and for other purposes.
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Making emergency supplemental appropriations for the fiscal year ending September 30, 2021, and for other purposes.
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 NDAA - provisions related to biological and chemical defense Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign. H.R. 2466 The State Opioid Response Grant Authorization Act H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce) HEROES Act - H.R.8406 - The Heroes Act S.4231 - Preparing for the Next Pandemic Act HEALS Act
Making emergency supplemental appropriations for the fiscal year ending September 30, 2021, and for other purposes.
Client: EMERGENT BIOSOLUTIONS INC. · Firm: ERVIN GRAVES STRATEGY GROUP, LLC
State Opioid Response Grants funding for FY 2021; H.R. 6395, NDAA for Fiscal Year 2021- provisions related to biological and chemical defense and access to naloxone; Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 7783, "Plasma Donation Awareness Act of 2020" co-sponsored by Rep. Scott Peters and Rep. Brad Wenstrup, and S. 4179, "Plasma Donation Awareness Act" co-sponsored by Sen. Amy Klobuchar and Sen. Roger Wicker that would simply add plasma to a blood donation awareness campaign; H.R. 2466 The State Opioid Response Grant Authorization Act; H.R. 7574-Strengthening Americas Strategic National Stockpile Act of 2020, as amended (Rep. Slotkin - Energy and Commerce); HEROES Act - H.R. 8406 - The Heroes Act; S.4231 - Preparing for the Next Pandemic Act; HEALS Act; H.R. 14, the Commitment to Defeat the Virus and Keep America Healthy Act; H.R. 133, Consolidated Appropriations Act 2021;
2026 · first_quarter · Q1
FY27 NDAA, FY27 Appropriations
FY27 NDAA, FY27 Appropriations
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2026 · first_quarter · Q1
Monitoring issues related to Information Technology Asset Visibility and Compliance
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2026 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2027- provisions relating to Spectrum policy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2026 · first_quarter · 1T
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanent magnets.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2026 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2027 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
GENERAL DYNAMICS via ERVIN GRAVES STRATEGY GROUP, LLC
2026 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2027; Defense Appropriations Act for Fiscal Year 2027; Shipbuilding Industrial Base Issues; R&D tax credit advocacy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
LISTER CHAIN & FORGE via ERVIN GRAVES STRATEGY GROUP, LLC
2026 · first_quarter · Q1
Advice and Counsel and preparations for Homeland Security Appropriations Bill for Fiscal Year 2027
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · fourth_quarter · Q4
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanent magnets.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · fourth_quarter · Q4
Monitoring issues related to Information Technology Asset Visibility and Compliance
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS)
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · fourth_quarter · Q4
FY26 NDAA, FY26 Appropriations
FY26 NDAA, FY26 Appropriations
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · fourth_quarter · Q4
National Defense Authorization Act for Fiscal Year 2025- provisions relating to Spectrum policy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · fourth_quarter · Q4
National Defense Authorization Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
GENERAL DYNAMICS via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · fourth_quarter · Q4
National Defense Authorization Act for Fiscal Year 2026; Defense Appropriations Act for Fiscal Year 2026; Shipbuilding Industrial Base Issues; R&D tax credit advocacy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
LISTER CHAIN & FORGE via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · fourth_quarter · Q4
Advice and Counsel and preparations for Defense Appropriations Bill and Defense Authorization Act for Fiscal Year 2026
COHERENT via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · 3T
National Defense Authorization Act for Fiscal Year 2026 - Silicon carbide Defense Appropriations Act for Fiscal Year 2026 - Silicon carbide CHIPS for America Act
Filing targets: SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · fourth_quarter · 4T
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Availability of domestic supply chain materials, mother and baby nutrition; FY 26 appropriations and funding for mother and baby nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanent magnets.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Availability of domestic supply chain materials, mother and baby nutrition; FY 26 appropriations and funding for mother and baby nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
FY26 NDAA, FY26 Appropriations
FY26 NDAA, FY26 Appropriations
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
Monitoring issues related to Information Technology Asset Visibility and Compliance
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS)
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
National Defense Authorization Act for Fiscal Year 2025- provisions relating to Spectrum policy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
National Defense Authorization Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
COHERENT via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
National Defense Authorization Act for Fiscal Year 2026 - Silicon carbide Defense Appropriations Act for Fiscal Year 2026 - Silicon carbide CHIPS for America Act
Filing targets: SENATE
GENERAL DYNAMICS via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
National Defense Authorization Act for Fiscal Year 2026; Defense Appropriations Act for Fiscal Year 2026; Shipbuilding Industrial Base Issues; R&D tax credit advocacy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
LYONDELLBASELL via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · 3T
Matters pertaining to supply chain and transportation, plastics, and chemical management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LISTER CHAIN & FORGE via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · third_quarter · Q3
Preparations for Defense Appropriations Bill for Fiscal Year 2026 and Defense Authorization Act for Fiscal Year 2026
LYONDELLBASELL via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · 2A
Matters pertaining to supply chain and transportation, plastics, and chemical management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · 2A
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Availability of domestic supply chain materials, mother and baby nutrition; FY 26 appropriations and funding for mother and baby nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LYONDELLBASELL via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
Matters pertaining to supply chain and transportation, plastics, and chemical management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanent magnets.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Availability of domestic supply chain materials, mother and baby nutrition; FY 26 appropriations and funding for mother and baby nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
FY26 NDAA, FY26 Appropriations
FY26 NDAA, FY26 Appropriations
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
Monitoring issues related to Information Technology Asset Visibility and Compliance
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS)
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2025- provisions relating to Spectrum policy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Veterans Affairs, Dept of (VA)
COHERENT via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2026 - Silicon carbide Defense Appropriations Act for Fiscal Year 2026 - Silicon carbide CHIPS for America Act
Filing targets: SENATE
GENERAL DYNAMICS via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2026; Defense Appropriations Act for Fiscal Year 2026; Shipbuilding Industrial Base Issues; R&D tax credit advocacy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
LISTER CHAIN & FORGE via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · second_quarter · Q2
Preparations for Defense Appropriations Bill for Fiscal Year 2026 and Defense Authorization Act for Fiscal Year 2026
LYONDELLBASELL via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
Matters pertaining to supply chain and transportation, plastics, and chemical management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanent magnets.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Availability of domestic supply chain materials, mother and baby nutrition; FY 26 appropriations and funding for mother and baby nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
FY26 NDAA, FY26 Appropriations
FY26 NDAA, FY26 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
Monitoring issues related to Information Technology Asset Visibility and Compliance
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2025- provisions relating to Spectrum policy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2026 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
COHERENT via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2026 - Silicon carbide Defense Appropriations Act for Fiscal Year 2026 - Silicon carbide CHIPS for America Act
Filing targets: SENATE
GENERAL DYNAMICS via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2026; Defense Appropriations Act for Fiscal Year 2026; Shipbuilding Industrial Base Issues; R&D tax credit advocacy.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
MARTIN'S POINT HEALTH CARE via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · 1T
Appropriations & Authorization Bills for Fiscal Year 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LISTER CHAIN & FORGE via ERVIN GRAVES STRATEGY GROUP, LLC
2025 · first_quarter · Q1
Preparations for Defense Appropriations Bill for Fiscal Year 2026 and Defense Authorization Act for Fiscal Year 2026;
LYONDELLBASELL via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
Matters pertaining to supply chain and transportation, plastics, and chemical management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanent magnets
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ELECTRA.AERO, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
Defense Authorization and Appropriations; NASA Authorization.
Filing targets: Defense, Dept of (DOD), SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
Availability of domestic supply chain materials, mother and baby nutrition; FY 25 appropriations and funding for mother and baby nutrition.
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
FY25 NDAA, FY25 Appropriations
FY25 NDAA, FY25 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
Monitoring issues related to Information Technology Asset Visibility and Compliance
Filing targets: Defense, Dept of (DOD)
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
National Defense Authorization Act for Fiscal Year 2025- provisions relating to Spectrum policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
National Defense Authorization Act for Fiscal Year 2025 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2025 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERENT via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
National Defense Authorization Act for Fiscal Year 2025 - Silicon carbide Defense Appropriations Act for Fiscal Year 2025 - Silicon carbide CHIPS for America Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
GENERAL DYNAMICS via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
National Defense Authorization Act for Fiscal Year 2025; Defense Appropriations Act for Fiscal Year 2025; Shipbuilding Industrial Base Issues; R&D tax credit advocacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARTIN'S POINT HEALTH CARE via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
Appropriations & Authorization Bills for Fiscal Year 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LISTER CHAIN & FORGE via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · Q4
Defense Appropriations Bill for Fiscal Year 2025 - provisions related to anchor and mooring chain; Buy America Act related issues; National Defense Authorization Act for Fiscal Year 2025
Filing targets: HOUSE OF REPRESENTATIVES
EMERGENT BIOSOLUTIONS INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · 4T
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; NDAA for Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EAGLE RIDGE RESOURCES LLC via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · fourth_quarter · RR
Critical and strategic materials, specifically rare earths, and US based conversion
LYONDELLBASELL via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
Research Issues; Advise client related to issues; No outreach to public officials during the period.
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanent magnets
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
ELECTRA.AERO, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
Defense Authorization and Appropriations; NASA Authorization.
Filing targets: Defense, Dept of (DOD), SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Availability of domestic supply chain materials, mother and baby nutrition; FY 25 appropriations and funding for mother and baby nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
FY25 NDAA, FY25 Appropriations
FY25 NDAA, FY25 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
Monitoring issues related to Information Technology Asset Visibility and Compliance
Filing targets: Defense, Dept of (DOD)
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
National Defense Authorization Act for Fiscal Year 2025- provisions relating to Spectrum policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; NDAA for Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
National Defense Authorization Act for Fiscal Year 2025 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2025 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERENT via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
National Defense Authorization Act for Fiscal Year 2025 - Silicon carbide Defense Appropriations Act for Fiscal Year 2025 - Silicon carbide CHIPS for America Act;
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
GENERAL DYNAMICS via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
National Defense Authorization Act for Fiscal Year 2025; Defense Appropriations Act for Fiscal Year 2025; Shipbuilding Industrial Base Issues; R&D tax credit advocacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARTIN'S POINT HEALTH CARE via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
Appropriations & Authorization Bills for Fiscal Year 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LISTER CHAIN & FORGE via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · Q3
Defense Appropriations Bill for Fiscal Year 2025 - provisions related to anchor and mooring chain; Buy America Act related issues; National Defense Authorization Act for Fiscal Year 2025;
Filing targets: HOUSE OF REPRESENTATIVES
LYONDELLBASELL via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · RR
Chemical and energy technology research, development and demonstration.
Chemical and energy technology research, development and demonstration.
ELECTRA.AERO, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · RA
Defense Authorization and Appropriations; NASA Authorization.
Defense Authorization and Appropriations; NASA Authorization.
5E ADVANCED MATERIALS, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · third_quarter · RA
Support for project regarding of the production of boric acid via solution mining of an ore body.
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanent magnets
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Availability of domestic supply chain materials, mother and baby nutrition; FY 25 appropriations and funding for mother and baby nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
FY25 NDAA, FY25 Appropriations
FY25 NDAA, FY25 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
Monitoring issues related to Information Technology Asset Visibility and Compliance
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2025- provisions relating to Spectrum policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2025 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2025 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERENT via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2025 - Silicon carbide Defense Appropriations Act for Fiscal Year 2025 - Silicon carbide CHIPS for America Act;
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
GENERAL DYNAMICS via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
National Defense Authorization Act for Fiscal Year 2025; Defense Appropriations Act for Fiscal Year 2025; Shipbuilding Industrial Base Issues; R&D tax credit advocacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARTIN'S POINT HEALTH CARE via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
Appropriations & Authorization Bills for Fiscal Year 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LISTER CHAIN & FORGE via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · Q2
Defense Appropriations Bill for Fiscal Year 2025 - provisions related to anchor and mooring chain; Buy America Act related issues; National Defense Authorization Act for Fiscal Year 2025;
Filing targets: HOUSE OF REPRESENTATIVES
TACTICAL INNOVATIONS LLC via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · second_quarter · 2T
Introductions of client services to government officials; Advice and counsel related to funding for client programs and technology.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
PMT GROUP via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · first_quarter · Q1
Promote and align client capability to support domestic requirement for critical materials, specifically the production of permanet magnets
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BYHEART, INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · first_quarter · Q1
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations
Availability of domestic supply chain materials, mother and baby nutrition; FY 24 appropriations and funding for mother and baby nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · first_quarter · Q1
FY25 NDAA, FY25 Appropriations
FY25 NDAA, FY25 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABSOLUTE SOFTWARE CORPORATION via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · first_quarter · Q1
Monitoring issues related to Information Technology Asset Visibility and Compliance
CTIA via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2024- provisions relating to Spectrum policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMERGENT BIOSOLUTIONS INC. via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · first_quarter · Q1
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRELLIX via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2024 - Provisions relating to cyber security and the intelligence community; Defense Appropriations Act for Fiscal Year 2024 - Provisions relating to cyber security and the intelligence community; VA cyber security concerns.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERENT via ERVIN GRAVES STRATEGY GROUP, LLC
2024 · first_quarter · Q1
National Defense Authorization Act for Fiscal Year 2024 - Silicon carbide Defense Appropriations Act for Fiscal Year 2024 - Silicon carbide CHIPS for America Act;
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE